Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Trial details
- Registry ID
- NCT02970968
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of GastroparesisNCT02970968 | Vanda Pharmaceuticals | Phase 2 | Completed | 2018-11Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |